Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

obal pharmaceutical companies are increasing their outsourcing needs to China.

"We are especially encouraged by the recent significant growth in our biologics services. We are expecting a strong performance for our biologics services in the coming third and fourth quarters.  These recent developments coupled with our growing reputation are helping to enhance our increasingly close partnerships with leading global and domestic companies, which will support our future growth."

William Dai, Chief Financial Officer, added, "We achieved our second quarter objectives despite continued pressures from wage inflation, higher material costs and the appreciation of the Renminbi.  Despite these headwinds, we managed our expenses exceptionally well and continue to improve employee productivity. We generated sales growth of 26% year-over-year and 11% quarter-over-quarter while our headcount remained flat compared to the first quarter of 2011. We are also seeing benefits from investments we made into managerial and supporting infrastructure in 2010, while progress at our new facilities in Fengxian continues, and construction remains on schedule. We will focus on managing our costs in the second half of the year, and are confident that we will meet our financial guidance for 2011."

Second Quarter 2011 ResultsNet revenues were $27.5 million, an increase of 26.0% from $21.8 million in the second quarter of 2010, primarily due to higher volumes from the Company's top customers, a larger customer base and expanded service offerings.  During the quarter, revenues also benefited from higher average FTE rates.During the quarter, the Company increased its customer base to 316 customers, an increase from 237 customers as of December 31, 2010 and 282 as of March 31, 2011.

Revenue from customers based in China rose by 202.7%.  The growth came from both local pharmaceutical companies and smaller domestic laborat
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
2. ShangPharma Announces First Quarter 2011 Results
3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
8. Neurologix Announces Second Quarter 2011 Financial Results
9. Bion Announces New U.S. Patent for Phosphorus Removal
10. ViaCyte Announces Executive Management Changes
11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Research and Markets ( ... new report "Gene Therapy - Technologies, Markets and ... for gene therapy are difficult to estimate as there ... is marketed in China since ... 2014-2024. The estimates are based on epidemiology of diseases ...
(Date:9/2/2015)... Sept. 2, 2015  Neurotech Pharmaceuticals, Inc., announced ... the multicenter Phase 2 clinical trial of NT-503 ... of recurrent subfoveal choroidal neovascularization secondary to age ... unique vascular endothelial growth factor (VEGF) receptor protein ... "This landmark proof-of-concept study will evaluate NT-503 ...
(Date:9/2/2015)... September 2, 2015 BioLight ... or the "Company"), a firm that invests in, ... cancer diagnostics, announced today that presentations highlighting its ... be delivered at the Ophthalmology Futures European Forum ... of Cataract & Refractive Surgeons ("ESCRS"), both taking ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Staff members will be attending Pharma Ed Resources upcoming educational seminar and ... of industry leading speakers, this timely conference will provide Updates & Case Studies ...
Breaking Biology Technology:Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 2Whitehouse Laboratories to Participate in Pharm Ed Resources Extractables, Leachables, & Elemental Impurities Educational Seminar 3
... , , SUNNYVALE, Calif., July ... endovascular devices for the treatment of chronic total occlusions (CTOs), today ... Operating Officer. Chris previously held the position of Executive VP, Sales ... in Medical Devices including the last 2 years at FlowCardia. , ...
... LONG BRANCH, N.J., July 23 The 2009 Pharma ... the current 500 attendees and 100 exhibitors have been posted ... Alexay of Apaporis LLC, the event organizer. Attendance is ... 2008,s record turnout. One thousand attendees are expected on ...
... , SEATTLE, July 23 Cell Therapeutics, Inc. (Nasdaq ... of an underwritten public offering of 29,332,107 shares of its common ... common stock at a price to the public of $1.30 per ... common stock, for gross proceeds of approximately $38.1 million. In ...
Cached Biology Technology:FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer 2ChemOutsourcing Unveils 2009 Attendee List for September Show in New Jersey 2Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants 2Cell Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock and Warrants 3
(Date:8/31/2015)... , August 31, 2015 ... biometrics technology in government digitization projects to drive ... a recently published TechSci Research report, " India Biometrics Market ... India is projected to grow at a CAGR ... market is anticipated on account of extensive use of biometric ...
(Date:8/25/2015)... and BELLEVUE, Wash. , Aug. ... advanced robotic systems, announced today it will unveil its ... vehicle (UGV), at the National Tactical Officers Association Conference ... The Guardian S is the first-ever commercially available ... years of research and in-field trials and is protected ...
(Date:8/20/2015)... Calif. , Aug. 20, 2015   ... focused on improving the user experience and security ... vision technologies, today announced that its TrulySecure™ ... biometric authentication software to be FIDO Certified™. ... TrulySecure for compliance with the FIDO UAF (Universal ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5
... Boulder, Colo., USA New Geology science ... draws on data from several sites in the U.S., ... South Australia, Japan, the southeastern Pacific, South Africa, and ... and volcanoes are discussed. Brief highlights follow. ...
... , A Simon Fraser University chemist is the ... scientific understanding of the structure and function of ... sugars on them., PLOS ONE , an international, ... published the paper, N-glycoproteome of E14.Tg2a Mouse Embryonic ...
... traditional coffee-growing techniques may be increasing the severity of ... through plantations in Central America and Mexico, according to ... The current outbreak of coffee rust is the ... fungal disease arrived in the region more than 40 ...
Cached Biology News:The Geological Society of America Journal Geology: Dynamic geoscience 2The Geological Society of America Journal Geology: Dynamic geoscience 3The Geological Society of America Journal Geology: Dynamic geoscience 4The Geological Society of America Journal Geology: Dynamic geoscience 5The Geological Society of America Journal Geology: Dynamic geoscience 6The Geological Society of America Journal Geology: Dynamic geoscience 7The Geological Society of America Journal Geology: Dynamic geoscience 8The Geological Society of America Journal Geology: Dynamic geoscience 9The Geological Society of America Journal Geology: Dynamic geoscience 10The Geological Society of America Journal Geology: Dynamic geoscience 11The Geological Society of America Journal Geology: Dynamic geoscience 12The Geological Society of America Journal Geology: Dynamic geoscience 13The Geological Society of America Journal Geology: Dynamic geoscience 14The Geological Society of America Journal Geology: Dynamic geoscience 15Discovering cell surface proteins' behavior 2Modern growing methods may be culprit of 'coffee rust' fungal outbreak 2Modern growing methods may be culprit of 'coffee rust' fungal outbreak 3
Incomplete Adjuvant...
... Lacks the mycobacteria found in Complete Freund's Adjuvant ... Incomplete, Freund's Adjuvant is used ... used to produce water-in-oil emulsions of immunogens. ... long-lasting antibody responses which can be attributed to ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
HiTrap Streptavidin HP, 5 x 1 ml. Category: Chromatography Systems & Accessories, Systems....
Biology Products: